Vectorite Biomedical Stock

Vectorite Biomedical Liabilities

The The Liabilities of Vectorite Biomedical (4170.TWO) as of Aug 4, 2026 is 24.48 M TWD. In the previous year, The Liabilities was 23.20 M TWD — a change of 5.53% (higher).

Liabilities

24.48 MTWD

YoY

5.53%

Last updated:

In 2026, Vectorite Biomedical's total liabilities amounted to 24.48 M TWD, a 5.53% difference from the 23.20 M TWD total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Vectorite Biomedical's Liabilities

Vectorite Biomedical's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Vectorite Biomedical's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Vectorite Biomedical's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Vectorite Biomedical's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Vectorite Biomedical’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Vectorite Biomedical stock

The Liabilities of Vectorite Biomedical is 24.48 M TWD in 2026.

The Liabilities of Vectorite Biomedical changed from 23.20 M TWD to 24.48 M TWD, representing a 5.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Vectorite Biomedical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Vectorite Biomedical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Vectorite Biomedical